Sunday, April 22, 2012 3:13:43 AM
ACAD..$1.48 Chart on watch. Pimavanserin Phase III data is due in Q3 (Sept).
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
